Literature DB >> 4919001

Clinical and laboratory evaluation of cephalexin in urinary-tract infections.

J F Acar, J G Baudens, Y A Chabbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4919001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  6 in total

Review 1.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Urinary tract infection.

Authors:  D Greenwood; R Slack
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

3.  Incompatibility groups and the classification of fi - resistance factors.

Authors:  Y A Chabbert; M R Scavizzi; J L Witchitz; G R Gerbaud; D H Bouanchaud
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

4.  Mobilization of plasmid-borne drug resistance determinants for transfer from Pseudomonas aeruginosa to Escherichia coli.

Authors:  R W Hedges; A E Jacob
Journal:  Mol Gen Genet       Date:  1975-09-15

5.  Elimination of bacteria in biliary tract infections during ceftizoxime therapy.

Authors:  E B Helm; D Wurbs; R Haag; D Bentele; P M Shah
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  Elimination of bacteria during antibacterial chemotherapy--a neglected parameter of chemotherapy.

Authors:  E B Helm; I Munk; P M Shah; W Stille
Journal:  Infection       Date:  1979       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.